LakeShore Biopharma
LSB was delisted on the 19th of September, 2025.
1 hedge funds and large institutions have $18.1K invested in LakeShore Biopharma in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
1.58% less ownership
Funds ownership: 1.7% → 0.12% (-1.6%)
86% less funds holding
Funds holding: 7 → 1 (-6)
95% less capital invested
Capital invested by funds: $330K → $18.1K (-$312K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$119K |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$76.7K |
| 3 |
O
OrbiMed
New York
|
-$55.9K |
| 4 |
SCM
Superstring Capital Management
New York
|
-$31.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$15.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $18.1K | – | – | – |
|
|
2
Fidelity Investments
Boston,
Massachusetts
| – | -$119K | -116,508 | Closed |
|
|
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
| – | -$76.7K | -75,179 | Closed |
|
|
O
4
OrbiMed
New York
| – | -$55.9K | -54,799 | Closed |
|
|
SCM
5
Superstring Capital Management
New York
| – | -$31.4K | -30,792 | Closed |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$15.3K | -14,963 | Closed |
|
7
UBS Group
Zurich,
Switzerland
| – | -$6.6K | -6,469 | Closed |
|
LSB Hedge Fund Activity: Q3 2025 in Review
1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma (LSB) for Q3 2025, worth a combined $18.1K — down 95% from $330K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LSB and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $119K sold.
- 1 institutional investor held LakeShore Biopharma (LSB) as of Q3 2025, down from 7 in Q2 2025.
- Funds reported $18.1K of LakeShore Biopharma stock for Q3 2025, down 95% quarter-over-quarter.
- 0 funds opened new LakeShore Biopharma positions in Q3 2025 and 6 closed out, a net change of -6 holders.
- The largest LakeShore Biopharma seller in Q3 2025 was Fidelity Investments, an estimated $119K sold.
Based on aggregated 13F filings for Q3 2025.